{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:55:18Z","timestamp":1790906118936,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ccl.2026.07.002","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:43:17Z","timestamp":1787744597000},"page":"623-634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current Medical Therapy in Epicardial and Microvascular Disease: Evidence and Gaps"],"prefix":"10.1016","volume":"44","author":[{"given":"Francesco","family":"Angeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Armillotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Bergamaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"36","key":"10.1016\/j.ccl.2026.07.002_bib1","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.ccl.2026.07.002_bib2","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jacc.2023.06.043","article-title":"Comprehensive management of ANOCA, part 1-Definition, patient population, and diagnosis: JACC state-of-the-art review","volume":"82","author":"Samuels","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2026.07.002_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6080258","article-title":"Updates on pharmacologic management of microvascular angina","volume":"2022","author":"Soleymani","year":"2022","journal-title":"Cardiovasc Ther"},{"issue":"11","key":"10.1016\/j.ccl.2026.07.002_bib4","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.116.024534","article-title":"Ischemia and no obstructive coronary artery disease (INOCA): developing evidence-based therapies and research agenda for the next decade","volume":"135","author":"Bairey Merz","year":"2017","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.ccl.2026.07.002_bib5","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.jacc.2010.01.054","article-title":"Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women\u2019s Ischemia Syndrome Evaluation) study","volume":"55","author":"Pepine","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.ccl.2026.07.002_bib6","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1136\/hrt.2010.206870","article-title":"Further insights into syndrome X","volume":"96","author":"Pizzi","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.ccl.2026.07.002_bib7","doi-asserted-by":"crossref","DOI":"10.15420\/ecr.2021.15","article-title":"Microvascular angina: diagnosis and management","volume":"16","author":"Aldiwani","year":"2021","journal-title":"Eur Cardiol"},{"issue":"5","key":"10.1016\/j.ccl.2026.07.002_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2025.103021","article-title":"Non-invasive imaging assessment in angina with non-obstructive coronary arteries (ANOCA)","volume":"50","author":"Bergamaschi","year":"2025","journal-title":"Curr Probl Cardiol"},{"issue":"7","key":"10.1016\/j.ccl.2026.07.002_bib9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/heartjnl-2024-324565","article-title":"Pathological findings at invasive assessment in MINOCA: a systematic review and meta-analysis","volume":"111","author":"Fedele","year":"2025","journal-title":"Heart"},{"issue":"23","key":"10.1016\/j.ccl.2026.07.002_bib10","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1161\/CIR.0000000000001394","article-title":"State of the art: evaluation and medical management of nonobstructive coronary artery disease in patients with chest pain: a scientific statement from the American heart Association","volume":"152","author":"Slipczuk","year":"2025","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccl.2026.07.002_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2026-004115","article-title":"Women\u2019s IschemiA TRial to reduce events in Non-ObstRuctive CAD (WARRIOR): a randomised controlled trial","volume":"13","author":"Pepine","year":"2026","journal-title":"Open Heart"},{"issue":"6","key":"10.1016\/j.ccl.2026.07.002_bib12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/eurjpc\/zwaf150","article-title":"Effects of cardiac rehabilitation on the severity of angina, health-related quality of life, and exercise capacity among adults living with microvascular angina: a systematic review and meta-analysis","volume":"33","author":"Oliveira","year":"2026","journal-title":"Eur J Prev Cardiol"},{"issue":"11","key":"10.1016\/j.ccl.2026.07.002_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240722","article-title":"Comprehensive treatment of microvascular angina in overweight women \u2013 a randomized controlled pilot trial","volume":"15","author":"Bove","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ccl.2026.07.002_bib14","doi-asserted-by":"crossref","DOI":"10.1177\/17539447241230400","article-title":"Vasospastic angina: a review on diagnostic approach and management","volume":"18","author":"Jenkins","year":"2024","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"42","key":"10.1016\/j.ccl.2026.07.002_bib15","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 focused update of the 2019 ESC\/EAS guidelines for the management of dyslipidaemias: developed by the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"46","author":"Mach","year":"2025","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.ccl.2026.07.002_bib16","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/S0195-668X(03)00478-0","article-title":"Benefits of statin treatment in cardiac syndrome-X1","volume":"24","author":"Kayikcioglu","year":"2003","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ccl.2026.07.002_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0167-5273(95)02458-9","article-title":"Effect of diltiazem on coronary flow reserve in patients with microvascular angina","volume":"52","author":"S\u00fctsch","year":"1995","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ccl.2026.07.002_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2025.133128","article-title":"An updated review on therapeutic strategies in coronary microvascular dysfunction","volume":"428","author":"Khandkar","year":"2025","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ccl.2026.07.002_bib19","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ahj.2011.07.011","volume":"162","author":"Pauly","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccl.2026.07.002_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pcad.2024.10.006","article-title":"Coronary microvascular dysfunction beyond the spectrum of chronic coronary syndromes","volume":"87","author":"Belmonte","year":"2024","journal-title":"Prog Cardiovasc Dis"},{"issue":"23 Pt A","key":"10.1016\/j.ccl.2026.07.002_bib21","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.jacc.2018.09.006","article-title":"Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial","volume":"72","author":"Ford","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccl.2026.07.002_bib22","first-page":"371","article-title":"Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X","volume":"9","author":"Sen","year":"2009","journal-title":"Anadolu Kardiyol Derg"},{"issue":"1","key":"10.1016\/j.ccl.2026.07.002_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0002-9149(85)90562-4","article-title":"Efficacy of carvedilol (BM 14,190), a new beta-blocking drug with vasodilating properties, in exercise-induced ischemia","volume":"56","author":"Kaski","year":"1985","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.ccl.2026.07.002_bib24","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jcmg.2022.03.012","article-title":"Efficacy of diltiazem to improve coronary vasomotor dysfunction in ANOCA: the EDIT-CMD randomized clinical trial","volume":"15","author":"Jansen","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.ccl.2026.07.002_bib25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0002-9149(85)90842-2","article-title":"Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve","volume":"56","author":"Cannon","year":"1985","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.ccl.2026.07.002_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000370027","article-title":"Poor tolerance and limited effects of isosorbide-5-mononitrate in microvascular angina","volume":"130","author":"Wu","year":"2015","journal-title":"Cardiology"},{"key":"10.1016\/j.ccl.2026.07.002_bib27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2017.08.068","article-title":"International standardization of diagnostic criteria for microvascular angina","volume":"250","author":"Ong","year":"2018","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.ccl.2026.07.002_bib28","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0002-9149(99)00450-6","article-title":"Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X","volume":"84","author":"Lanza","year":"1999","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.ccl.2026.07.002_bib29","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jacc.2006.10.074","article-title":"Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans: evidence of a free-radical-mediated mechanism","volume":"49","author":"Thomas","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"41","key":"10.1016\/j.ccl.2026.07.002_bib30","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/eurheartj\/ehs100","article-title":"Chronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression","volume":"34","author":"Oelze","year":"2013","journal-title":"Eur Heart J"},{"issue":"42","key":"10.1016\/j.ccl.2026.07.002_bib31","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.3748\/wjg.14.6506","article-title":"Origin of and therapeutic approach to cardiac syndrome X: results of the proton pump inhibitor therapy for angina-like lingering pain trial (PITFALL trial)","volume":"14","author":"Dietrich","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"19","key":"10.1016\/j.ccl.2026.07.002_bib32","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/eurheartj\/ehv647","article-title":"A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve","volume":"37","author":"Bairey","year":"2016","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ccl.2026.07.002_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102457","article-title":"Sex- and gender-related disparities in chest pain syndromes: the feminine mystique of chest pain","volume":"49","author":"Angeli","year":"2024","journal-title":"Curr Probl Cardiol"},{"issue":"4","key":"10.1016\/j.ccl.2026.07.002_bib34","first-page":"775","article-title":"Pathophysiological mechanisms linking depression and atherosclerosis: an overview","volume":"26","author":"Pizzi","year":"2012","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.ccl.2026.07.002_bib35","article-title":"Gender and Sex-related differences in type 2 myocardial infarction: the undervalued side of a neglected disease","author":"Angeli","year":"2025","journal-title":"Trends Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.ccl.2026.07.002_bib36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/eurheartj\/ehaa820","article-title":"Management of refractory angina: an update","volume":"42","author":"Davies","year":"2021","journal-title":"Eur Heart J"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865126000706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865126000706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:17:38Z","timestamp":1790903858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865126000706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0733865126000706"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2026.07.002","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Medical Therapy in Epicardial and Microvascular Disease: Evidence and Gaps","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2026.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}